中国药业
中國藥業
중국약업
China Pharmaceuticals
2015年
17期
25-26
,共2页
夏枯草口服液%乳腺增生%临床疗效%彩色多普勒
夏枯草口服液%乳腺增生%臨床療效%綵色多普勒
하고초구복액%유선증생%림상료효%채색다보륵
Xiakucao Oral Solution%hyPerPlasia%clinical efficacy%color doPPler
目的：探讨夏枯草口服液治疗乳腺增生患者的临床疗效以及超声学改变。方法选择2012年12月至2014年8月医院收治的乳腺增生患者120例，随机分为对照组和观察组，各60例。两组患者均服用乳癖消胶囊，观察组加用夏枯草口服液。结果观察组总有效率为96.67％，高于对照组的85.00％（ P＜0.05）。治疗后两组患者的病灶情况、腺体厚度、增生肿块最大直径、导管直径均显著改善，且观察组显著优于对照组（ P＜0.05）。两组不良反应均较轻，发生率差异无统计学意义（ P＞0.05）。结论乳腺增生患者加用夏枯草口服液进行治疗，临床疗效显著，可有效改善患者临床症状及B超检查结果，且无明显不良反应，值得临床推广。
目的：探討夏枯草口服液治療乳腺增生患者的臨床療效以及超聲學改變。方法選擇2012年12月至2014年8月醫院收治的乳腺增生患者120例，隨機分為對照組和觀察組，各60例。兩組患者均服用乳癖消膠囊，觀察組加用夏枯草口服液。結果觀察組總有效率為96.67％，高于對照組的85.00％（ P＜0.05）。治療後兩組患者的病竈情況、腺體厚度、增生腫塊最大直徑、導管直徑均顯著改善，且觀察組顯著優于對照組（ P＜0.05）。兩組不良反應均較輕，髮生率差異無統計學意義（ P＞0.05）。結論乳腺增生患者加用夏枯草口服液進行治療，臨床療效顯著，可有效改善患者臨床癥狀及B超檢查結果，且無明顯不良反應，值得臨床推廣。
목적：탐토하고초구복액치료유선증생환자적림상료효이급초성학개변。방법선택2012년12월지2014년8월의원수치적유선증생환자120례，수궤분위대조조화관찰조，각60례。량조환자균복용유벽소효낭，관찰조가용하고초구복액。결과관찰조총유효솔위96.67％，고우대조조적85.00％（ P＜0.05）。치료후량조환자적병조정황、선체후도、증생종괴최대직경、도관직경균현저개선，차관찰조현저우우대조조（ P＜0.05）。량조불량반응균교경，발생솔차이무통계학의의（ P＞0.05）。결론유선증생환자가용하고초구복액진행치료，림상료효현저，가유효개선환자림상증상급B초검사결과，차무명현불량반응，치득림상추엄。
Objective To investigate the clinical efficacy and ultrasonics change of Xiakucao Oral Solution in the treatment of breast hy-PerPlasia. Methods 120 Patients form December 2012 to August 2014 in the hosPital with breast hyPerPlasia were selected given ran-domly divided into the control and the treatment grouPs,60 cases in each grouP. Two grouPs of Patients were RuPixiao,and the observa-tion grouP,on the basis of the control grouP,were given Xiakucao Oral Solution. Results The total effective rate in the observation grouP was 96. 67%,which was higher than 85. 00% in the control grouP ( P < 0. 05 ) . Before treatment,the lesions of the case,the thickness of the gland hyPerPlasia tumor maximum diameter,vessel diameter change of the two grouPs had no significant differences;af-ter treatment,both grouPs imProved and the observation grouP imProved more than the control grouP ( P < 0. 05 ) . The adverse reactions in both grouPs were mild,with no statistically significant difference ( P > 0. 05 ) . Conclusion Adding Xiakucao Oral Solution in the treatment for Patients with breast hyPerPlasia has significant clinical effect,can effectively imProve the clinical symPtoms and the tyPe-B ultrasonic test results,and has no significant adverse reactions,is worthy of clinical aPPlication.
